PUCKETT DAN 4

What Happened
Dan Puckett, a director of PROCEPT BioRobotics (PRCT), received two compensation awards on March 5, 2026: 5,476 restricted stock units (RSUs) and a stock option covering 8,897 shares. Both awards were granted at $0.00 (no cash paid). The filing reports the RSUs as contingent rights to shares and the option as a derivative grant; neither reflects an open-market purchase or sale.

Key Details

• Transaction date(s): March 5, 2026; Form 4 filed March 9, 2026.
• Price: $0.00 for both the RSUs and the stock option (standard for compensation grants).
• Shares/units granted: 5,476 RSUs; stock option for 8,897 shares.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Vesting/footnotes:
  • RSUs: each unit converts to one share; one-third vests on March 5, 2027, then one-third on each of the next two anniversaries, subject to continued service.
  • Stock option: granted March 5, 2026; one-third vests on March 5, 2027, then one-third on each of the next two anniversaries, subject to continued service.
• Timeliness: filing posted four calendar days after the transaction date; Form 4s are typically required within two business days (check the full filing for any remarks on timeliness).

Context

• These awards are compensation grants (RSUs and an option) that vest over three years if the director continues service; they are not exercises or market purchases/sales. Such grants are common for board compensation and do not by themselves indicate immediate buying or selling of shares.